...
首页> 外文期刊>Epilepsia: Journal of the International League against Epilepsy >Teratogenesis in repeated pregnancies in antiepileptic drug-treated women
【24h】

Teratogenesis in repeated pregnancies in antiepileptic drug-treated women

机译:抗癫痫药物治疗的女性反复妊娠中的致畸作用

获取原文
获取原文并翻译 | 示例

摘要

Purpose: Considerable information is now available concerning the risk of teratogenesis in the individual pregnancy exposed to antiepileptic drugs (AEDs). However, there is comparatively little information available concerning the risk in the subsequent pregnancies of women who continue to take the AED associated with a fetal malformation in a previous pregnancy. This article addresses this matter. Methods: Analysis of data concerning fetal abnormalities in 1,243 women who had 2,637 pregnancies between mid-1999 and 2010 recorded in the Australian Register of Antiepileptic Drugs in Pregnancy. Of the 2,637 pregnancies, 1,114 had been completed before initial enrolment in the Register. Key Findings: Women taking any AED who had given birth to a malformed baby in their first enrolled pregnancy and who continue taking the same drug were at increased risk of having a malformed offspring in their next pregnancy (35.7% vs. 3.1%; odds ratio [OR] 17.6; 95% confidence interval [95% CI] 4.5-68.7). Among these women, those taking valproate (VPA) were more likely to have malformed fetuses in their next pregnancies than those who had taken VPA without fetal abnormalities (57.2% vs. 7.0%, OR 17.8; 95% CI 2.7, 119.1). There were similar although not statistically significant trends in those who had taken AEDs other than VPA. Similar, although again not statistically significant, trends were found, when considering the pairings of the most recent preenrollment pregnancy and the following one. If a woman had two or more pregnancies that resulted in AED-associated fetal malformation, the types of malformation were often different. Significance: Women whose last pregnancy resulted in a fetal malformation have a substantially increased risk of having further malformed fetuses if they become pregnant again while taking the same AED, particularly VPA. This suggests that maternal factors, perhaps genomic, predispose to at least VPA-associated malformations. This knowledge, together with information about the outcome of any previous pregnancy, should help in advising women with AED-treated epilepsy who plan further pregnancies.
机译:目的:关于抗癫痫药(AED)的个体妊娠中致畸风险的信息现已可知。但是,关于在先前怀孕期间继续服用与胎儿畸形有关的AED的妇女随后怀孕的风险的信息很少。本文解决此问题。方法:对澳大利亚抗癫痫药物怀孕登记簿中记录的1999年中至1,243例2 637例孕妇中胎儿异常的数据进行分析。在2637例怀孕中,有1114例在首次注册之前就已经完成。主要发现:第一次接受妊娠时服用任何AED并产下畸形婴儿并继续服用相同药物的妇女,其下一次妊娠后代畸形的风险增加(35.7%vs. 3.1%;优势比) [OR] 17.6; 95%置信区间[95%CI] 4.5-68.7)。在这些妇女中,服用丙戊酸盐(VPA)的妇女与未发生胎儿异常的VPA的妇女相比,下一次怀孕的胎儿畸形的可能性更高(57.2%比7.0%,或17.8; 95%CI 2.7,119.1)。除了服用VPA以外,服用AED的患者有相似但不具有统计学意义的趋势。在考虑最近的入学前妊娠和随后的入学妊娠配对时,发现了相似的(尽管同样在统计学上不显着)趋势。如果一名妇女怀孕两次或两次以上导致AED相关的胎儿畸形,则畸形的类型通常会有所不同。启示:如果最后一次怀孕导致胎儿畸形的妇女在服用相同的AED尤其是VPA的同时再次怀孕,则其胎儿进一步畸形的风险会大大增加。这表明孕产因素,可能是基因组因素,易患至少VPA相关的畸形。这些知识以及有关任何先前妊娠结局的信息,应有助于为计划进一步妊娠的经AED治疗的癫痫患者提供建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号